1
|
Shen H, Zhou W, ChunrongTu, Peng Y, Li X, Liu D, Wang X, Zhang X, Zeng X, Zhang J. Thoracic aorta injury detected by 4D flow MRI predicts subsequent main adverse cardiovascular events in breast cancer patients receiving anthracyclines: A longitudinal study. Magn Reson Imaging 2024; 109:67-73. [PMID: 38484947 DOI: 10.1016/j.mri.2024.03.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2024] [Revised: 03/02/2024] [Accepted: 03/08/2024] [Indexed: 04/09/2024]
Abstract
PURPOSE To investigate longitudinal thoracic aorta injury using 3-dimensional phase-contrast magnetic resonance imaging (4D flow MRI) parameters and to evaluate their value for predicting the subsequent main adverse cardiovascular events (MACEs) in breast cancer patients receiving anthracyclines. METHODS Between July 2020 and July 2021, eighty-eight female participants with breast cancer scheduled to receive anthracyclines with or without trastuzumab prospectively enrolled. Each subjects underwent 4D flow MRI at baseline, 3 and 6 months in relation to baseline. The diameter, peak velocity (Vpeak), wall shear stress (WSS), pulse wave velocity (PWV), energy loss (EL) and pressure gradient (PG) of thoracic aorta were measured. The association between these parameters and subsequent MACEs was performed by Cox proportional hazard models. RESULTS Ten participants had subsequently MACEs. The Vpeak and PG gradually decreased and the WSS, PWV and EL progressively increased at 3 and 6 months compared with baseline. Adjusted multivariable analysis showed that the WSS of the proximal, mid- and distal ascending aorta [HR, 1.314 (95% confidence interval (CI): 1.003, 1.898)], [HR, 1.320 (95% CI: 1.002, 1.801)] and [HR, 1.322 (95% CI: 1.001, 1.805)] and PWV of ascending aorta [HR, 2.223 (95% CI: 1.010, 4.653)] at 3 months were associated with subsequent MACEs. Combined WSS and PWV of ascending aorta at 3 months yielded the highest AUC (0.912) for predicting subsequent MACEs. CONCLUSION Combined WSS and PWV of ascending aorta at 3 months is helpful for predicting the subsequent MACEs in breast cancer patients treated by anthracyclines.
Collapse
Affiliation(s)
- Hesong Shen
- Department of Radiology, Chongqing University Cancer Hospital & ChongqingCancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China
| | - Wenqi Zhou
- Department of Breast Cancer Center, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China
| | - ChunrongTu
- Department of Radiology, Chongqing University Cancer Hospital & ChongqingCancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China
| | - Yangling Peng
- Department of Radiology, Chongqing University Cancer Hospital & ChongqingCancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China
| | - Xiaoqin Li
- Department of Radiology, Chongqing University Cancer Hospital & ChongqingCancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China
| | - Daihong Liu
- Department of Radiology, Chongqing University Cancer Hospital & ChongqingCancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China
| | - Xiaoxia Wang
- Department of Radiology, Chongqing University Cancer Hospital & ChongqingCancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China
| | - Xiaoyong Zhang
- Clinical Science, Philips Healthcare, 1268 Tianfu Avenue, Hitech Zone, Chengdu, China
| | - Xiaohua Zeng
- Department of Breast Cancer Center, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China.
| | - Jiuquan Zhang
- Department of Radiology, Chongqing University Cancer Hospital & ChongqingCancer Institute & Chongqing Cancer Hospital, 181 Hanyu Road, Shapingba District, Chongqing, China.
| |
Collapse
|